12:00 AM
 | 
Jan 01, 2007
 |  BioCentury  |  Finance

Index performance

Index performance

Index performance
Continential biotechs continued their strong performance in the fourth quarter, with the BioCentury Europe index up 29%. The uptick was...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >